442 related articles for article (PubMed ID: 11004133)
1. Haemophilus influenzae infection and Guillain-Barré syndrome.
Mori M; Kuwabara S; Miyake M; Noda M; Kuroki H; Kanno H; Ogawara K; Hattori T
Brain; 2000 Oct; 123 ( Pt 10)():2171-8. PubMed ID: 11004133
[TBL] [Abstract][Full Text] [Related]
2. Haemophilus influenzae as a possible cause of Guillain-Barré syndrome.
Ju YY; Womersley H; Pritchard J; Gray I; Hughes RA; Gregson NA
J Neuroimmunol; 2004 Apr; 149(1-2):160-6. PubMed ID: 15020076
[TBL] [Abstract][Full Text] [Related]
3. Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain-Barré syndrome.
Mori M; Kuwabara S; Miyake M; Dezawa M; Adachi-Usami E; Kuroki H; Noda M; Hattori T
Neurology; 1999 Apr; 52(6):1282-4. PubMed ID: 10214761
[TBL] [Abstract][Full Text] [Related]
4. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
Gregson NA; Koblar S; Hughes RA
Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
[TBL] [Abstract][Full Text] [Related]
6. Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.
Jacobs BC; Koga M; van Rijs W; Geleijns K; van Doorn PA; Willison HJ; Yuki N
J Neuroimmunol; 2008 Feb; 194(1-2):181-90. PubMed ID: 18178257
[TBL] [Abstract][Full Text] [Related]
7. [Antibodies to ganglioside GM1 and Campylobacter jejuni in patients with Guillain-Barré syndrome].
Basta I; Suturkova L; Vujić A; Aleksić S; Poceva A; Paskoska A; Milenikova K; Trikić R; Apostolski S
Srp Arh Celok Lek; 2005; 133(3-4):123-8. PubMed ID: 16206698
[TBL] [Abstract][Full Text] [Related]
8. The role of cytomegalovirus, Haemophilus influenzae and Epstein Barr virus in Guillain Barre syndrome.
Nafissi S; Vahabi Z; Sadeghi Ghahar M; Amirzargar AA; Naderi S
Acta Med Iran; 2013 Jul; 51(6):372-6. PubMed ID: 23852841
[TBL] [Abstract][Full Text] [Related]
9. Anti-GM1 antibody IgG subclass: a clinical recovery predictor in Guillain-Barré syndrome.
Koga M; Yuki N; Hirata K; Morimatsu M; Mori M; Kuwabara S
Neurology; 2003 May; 60(9):1514-8. PubMed ID: 12743241
[TBL] [Abstract][Full Text] [Related]
10. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenesis of axonal Guillain-Barré syndrome].
Yuki N
Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
[TBL] [Abstract][Full Text] [Related]
13. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside.
Yuki N; Yamada M; Koga M; Odaka M; Susuki K; Tagawa Y; Ueda S; Kasama T; Ohnishi A; Hayashi S; Takahashi H; Kamijo M; Hirata K
Ann Neurol; 2001 Jun; 49(6):712-20. PubMed ID: 11409422
[TBL] [Abstract][Full Text] [Related]
14. Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients.
Caudie C; Quittard Pinon A; Taravel D; Sivadon-Tardy V; Orlikowski D; Rozenberg F; Sharshar T; Raphaël JC; Gaillard JL
J Neurol; 2011 Nov; 258(11):1958-64. PubMed ID: 21516465
[TBL] [Abstract][Full Text] [Related]
15. Range of cross reactivity of anti-GM1 IgG antibody in Guillain-Barré syndrome.
Koga M; Tatsumoto M; Yuki N; Hirata K
J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):123-4. PubMed ID: 11413278
[TBL] [Abstract][Full Text] [Related]
16. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
[TBL] [Abstract][Full Text] [Related]
17. Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a.
Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
Brain; 2000 Jan; 123 ( Pt 1)():116-24. PubMed ID: 10611126
[TBL] [Abstract][Full Text] [Related]
18. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.
Rees JH; Gregson NA; Hughes RA
Ann Neurol; 1995 Nov; 38(5):809-16. PubMed ID: 7486873
[TBL] [Abstract][Full Text] [Related]
19. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
Yuki N; Odaka M
Curr Opin Neurol; 2005 Oct; 18(5):557-61. PubMed ID: 16155440
[TBL] [Abstract][Full Text] [Related]
20. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
Tang J; Yuan J; Hao H
Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
